nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

12.09.2022 | Original Paper

Elevated levels of serotonin 5-HT_2A receptors in the orbitofrontal cortex of antisocial individuals

verfasst von: Giulia Braccagni, Simona Scheggi, Marco Bortolato

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Antisocial behavior (ASB) is characterized by frequent violations of the rights and properties of others, as well as aggressive conduct. While ample evidence points to a critical role of serotonin in the emotional modulation of social responses, the implication of this neurotransmitter in ASB is unclear. Here, we performed the first-ever postmortem analysis of serotonergic markers in the orbitofrontal cortex (OFC) of male subjects with ASB (n = 9). We focused on this brain region, given its well-recognized role in social response and ASB pathophysiology. Given that all individuals also had a substance use disorder (SUD) diagnosis, two age-matched control groups were used: SUD only and unaffected controls. Tissues were processed for immunoblotting analyses on eight key serotonergic targets: tryptophan hydroxylase 2 (TPH2), the rate-limiting enzyme of brain serotonin synthesis; serotonin transporter (SERT), the primary carrier for serotonin uptake; monoamine oxidase A (MAOA), the primary enzyme for serotonin catabolism; and five serotonin receptors previously shown to influence social behavior: 5-HT_1A, 5-HT_1B, 5-HT_2A, 5-HT_2C, and 5-HT₄. Our analyses documented a significant increase in 5-HT_2A receptor levels in the ASB + SUD group compared to SUD-only controls. Furthermore, TPH2 levels were significantly reduced in the SUD group (including SUD only and ASB + SUD) compared to unaffected controls. No difference was detected in the expression of any other serotonergic target. These results are in keeping with previous evidence showing high 5-HT_2A receptor binding in the OFC of pathologically aggressive individuals and point to this molecule as a potential target for ASB treatment.

Vitiello B, Stoff DM (1997) Subtypes of aggression and their relevance to child psychiatry. J Am Acad Child Adolesc Psychiatry 36(3):307–315. https://doi.org/10.1097/00004583-199703000-00008CrossRefPubMed

Nock MK, Kazdin A, Hiripi E, Kessler RC (2006) Prevalence, subtypes, and correlates of DSM-IV conduct disorder in the National Comorbidity Survey Replication. Psychol Med 36(5):699–710. https://doi.org/10.1017/S0033291706007082CrossRefPubMedPubMedCentral

Lenzenweger MF, Lane MC, Loranger AW, Kessler RC (2007) DSM-IV personality disorders in the national comorbidity survey replication. Biol Psychiatry 62(6):553–564. https://doi.org/10.1016/j.biopsych.2006.09.019CrossRefPubMedPubMedCentral

Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ (2010) Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord 24(4):412–426. https://doi.org/10.1521/pedi.2010.24.4.412CrossRefPubMedPubMedCentral

Grant BF, Hasin DS, Stinson FS et al (2004) Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 65(7):948–958. https://doi.org/10.4088/JCP.V65N0711CrossRefPubMed

Maughan B, Rowe R, Messer J, Goodman R, Meltzer H (2004) Conduct disorder and oppositional defiant disorder in a national sample: developmental epidemiology. J Child Psychol Psychiatry 45(3):609–621. https://doi.org/10.1111/J.1469-7610.2004.00250.XCrossRefPubMed

Hamdi NR, Iacono WG (2014) Lifetime prevalence and comorbidity of externalizing disorders and depression in prospective assessment. Psychol Med 44(2):315–324. https://doi.org/10.1017/S0033291713000627CrossRefPubMed

Nouvion SO, Cherek DR, Lane SD, Tcheremissine OV, Lieving LM (2007) Human proactive aggression: association with personality disorders and psychopathy. Aggress Behav 33(6):552–562. https://doi.org/10.1002/AB.20220CrossRefPubMed

Lobbestael J, Cima M, Arntz A (2013) The relationship between adult reactive and proactive aggression, hostile interpretation bias, and antisocial personality disorder. J Pers Disord 27(1):53–66. https://doi.org/10.1521/PEDI.2013.27.1.53CrossRefPubMed

10.

Connor DF, Ford JD, Albert DB, Doerfler LA (2007) Conduct disorder subtype and comorbidity. Ann Clin Psychiatry 19(3):161–168. https://doi.org/10.1080/10401230701465269CrossRefPubMed

11.

Black DW (2015) The Natural History of Antisocial Personality Disorder. Can J Psychiatry 60(7):309–314. https://doi.org/10.1177/070674371506000703CrossRefPubMedPubMedCentral

12.

Nichita EC, Buckley PF(2020) Comorbidities of Antisocial Personality Disorder. The Wiley International Handbook on Psychopathic Disorders and the Law. Published online August 17, 645–670. https://doi.org/10.1002/9781119159322.CH28

13.

Reebye P, Moretti MM, Lessard JC (1995) Conduct disorder and substance use disorder: comorbidity in a clinical sample of preadolescents and adolescents. Can J Psychiatry 40(6):313–319. https://doi.org/10.1177/070674379504000606CrossRefPubMed

14.

Messina NP, Wish ED, Nemes S (1999) Therapeutic community treatment for substance abusers with antisocial personality disorder. J Subst Abuse Treat 17(1–2):121–128. https://doi.org/10.1016/S0740-5472(98)00066-XCrossRefPubMed

15.

Krueger RF, Skodol AE, Livesley WJ, Shrout PE, Huang Y. (2007) Synthesizing dimensional and categorical approaches to personality disorders: refining the research agenda for DSM-V Axis II. Int J Methods Psychiatr Res 16:S65–73. Available from: https://onlinelibrary.wiley.com/doi/https://doi.org/10.1002/mpr.212

16.

Forbes MK, Kotov R, Ruggero CJ, Watson D, Zimmerman M, Krueger RF (2017) Delineating the joint hierarchical structure of clinical and personality disorders in an outpatient psychiatric sample. Compr Psychiatry 79:19–30. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0010440X17300512

17.

Marsh AA, Blair RJR (2008) Deficits in facial affect recognition among antisocial populations: a meta-analysis. Neurosci Biobehav Rev 32(3):454–465. https://doi.org/10.1016/J.NEUBIOREV.2007.08.003CrossRefPubMed

18.

Blair RJR (2003) Facial expressions, their communicatory functions and neuro-cognitive substrates. Philos Trans R Soc Lond B Biol Sci 358(1431):561–572. https://doi.org/10.1098/RSTB.2002.1220CrossRefPubMedPubMedCentral

19.

Montagne B, Kessels RPC, Frigerio E, de Haan EHF, Perrett DI (2005) Sex differences in the perception of affective facial expressions: do men really lack emotional sensitivity? Cogn Process 6(2):136–141. https://doi.org/10.1007/S10339-005-0050-6CrossRefPubMed

20.

Walker DW, Leister C (1994) Recognition of Facial Affect Cues by Adolescents with Emotional and Behavioral Disorders. Behav Disorders 19(4):269–276. https://doi.org/10.1177/019874299401900408CrossRef

21.

Bechara A, Damasio H, Damasio AR (2000) Emotion, decision making and the orbitofrontal cortex. Cereb Cortex 10(3):295–307. https://doi.org/10.1093/CERCOR/10.3.295CrossRefPubMed

22.

Blair RJR, Cipolotti L (2000) Impaired social response reversal. A case of “acquired sociopathy.” Brain. 123 (Pt 6)(6):1122–1141. https://doi.org/10.1093/BRAIN/123.6.1122

23.

Blair RJR (2004) The roles of orbital frontal cortex in the modulation of antisocial behavior. Brain Cogn 55(1):198–208. https://doi.org/10.1016/S0278-2626(03)00276-8CrossRefPubMed

24.

Lavarco A, Ahmad N, Archer Q et al (2022) Self-conscious emotions and the right fronto-temporal and right temporal parietal junction. Brain Sci 12(2):138. https://doi.org/10.3390/BRAINSCI12020138CrossRefPubMedPubMedCentral

25.

Zald DH (2009) Orbitofrontal cortex contributions to food selection and decision making. Ann Behav Med 38(Suppl 1):S18-24. https://doi.org/10.1007/S12160-009-9117-4CrossRefPubMed

26.

Carlisi CO, Moffitt TE, Knodt AR et al (2020) Associations between life-course-persistent antisocial behaviour and brain structure in a population-representative longitudinal birth cohort. Lancet Psychiatry 7(3):245–253. https://doi.org/10.1016/S2215-0366(20)30002-XCrossRefPubMedPubMedCentral

27.

Raine A, Lencz T, Bihrle S, LaCasse L, Colletti P (2000) Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder. Arch Gen Psychiatry 57(2):119–127. https://doi.org/10.1001/ARCHPSYC.57.2.119CrossRefPubMed

28.

Gansler DA, McLaughlin NCR, Iguchi L et al (2009) A multivariate approach to aggression and the orbital frontal cortex in psychiatric patients. Psychiatry Res 171(3):145–154. https://doi.org/10.1016/J.PSCYCHRESNS.2008.03.007CrossRefPubMed

29.

Hofhansel L, Weidler C, Votinov M, Clemens B, Raine A, Habel U (2020) Morphology of the criminal brain: gray matter reductions are linked to antisocial behavior in offenders. Brain Struct Funct 225(7):2017–2028. https://doi.org/10.1007/S00429-020-02106-6CrossRefPubMedPubMedCentral

30.

Ranganath C, Johnson MK, D’Esposito M (2003) Prefrontal activity associated with working memory and episodic long-term memory. Neuropsychologia 41(3):378–389. https://doi.org/10.1016/s0028-3932(02)00169-0CrossRefPubMed

31.

Rygula R, Clarke HF, Cardinal RN et al (2015) Role of central serotonin in anticipation of rewarding and punishing outcomes: effects of selective amygdala or orbitofrontal 5-ht depletion. Cereb Cortex 25(9):3064–3076. https://doi.org/10.1093/CERCOR/BHU102CrossRefPubMed

32.

Åsberg M (1997) Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann N Y Acad Sci 836:158–181. https://doi.org/10.1111/J.1749-6632.1997.TB52359.XCrossRefPubMed

33.

Bortolato M, Pivac N, Muck Seler D, Nikolac Perkovic M, Pessia M, di Giovanni G (2013) The role of the serotonergic system at the interface of aggression and suicide. Neuroscience 236:160–185. https://doi.org/10.1016/J.NEUROSCIENCE.2013.01.015CrossRefPubMed

34.

Yang Y, Raine A (2009) Prefrontal structural and functional brain imaging findings in antisocial, violent, and psychopathic individuals: A meta-analysis. Psychiatry Res Neuroimag 174:81–8. https://linkinghub.elsevier.com/retrieve/pii/S0925492709000882

35.

Blair RJR, Morris JS, Frith CD, Perrett DI, Dolan RJ (1999) Dissociable neural responses to facial expressions of sadness and anger. Brain 122:883–93. https://academic.oup.com/brain/article-lookup/doi/https://doi.org/10.1093/brain/122.5.883

36.

Gürtler A, Kunz N, Gomolka M, Hornhardt S, Friedl AA, McDonald K, et al (2013) Stain-Free technology as a normalization tool in Western blot analysis. Anal Biochem 433:105–11. https://linkinghub.elsevier.com/retrieve/pii/S000326971200512X

37.

Rivero-Gutiérrez B, Anzola A, Martínez-Augustin O, De Medina FS (2014) Stain-free detection as loading control alternative to Ponceau and housekeeping protein immunodetection in Western blotting. Anal Biochem 467:1–3CrossRefPubMed

38.

Rogers JC, de Brito SA (2016) Cortical and subcortical gray matter volume in youths with conduct problems: a meta-analysis. JAMA Psychiat 73(1):64–72. https://doi.org/10.1001/JAMAPSYCHIATRY.2015.2423CrossRef

39.

Waider J, Araragi N, Gutknecht L, Lesch KP (2011) Tryptophan hydroxylase-2 (TPH2) in disorders of cognitive control and emotion regulation: a perspective. Psychoneuroendocrinology 36(3):393–405. https://doi.org/10.1016/J.PSYNEUEN.2010.12.012CrossRefPubMed

40.

Gutknecht L, Popp S, Waider J et al (2015) Interaction of brain 5-HT synthesis deficiency, chronic stress and sex differentially impact emotional behavior in Tph2 knockout mice. Psychopharmacology 232(14):2429. https://doi.org/10.1007/S00213-015-3879-0CrossRefPubMedPubMedCentral

41.

Haberstick BC, Smolen A, Hewitt JK (2006) Family-based association test of the 5HTTLPR and aggressive behavior in a general population sample of children. Biol Psychiatry 59(9):836–843. https://doi.org/10.1016/J.BIOPSYCH.2005.10.008CrossRefPubMed

42.

Beitchman JH, Baldassarra L, Mik H et al (2006) Serotonin transporter polymorphisms and persistent, pervasive childhood aggression. Am J Psychiatry 163(6):1103–1105. https://doi.org/10.1176/AJP.2006.163.6.1103CrossRefPubMed

43.

Oades RD, Lasky-Su J, Christiansen H et al (2008) The influence of serotonin- and other genes on impulsive behavioral aggression and cognitive impulsivity in children with attention-deficit/hyperactivity disorder (ADHD): Findings from a family-based association test (FBAT) analysis. Behav Brain Funct 4:48. https://doi.org/10.1186/1744-9081-4-48CrossRefPubMedPubMedCentral

44.

Payer DE, Nurmi EL, Wilson SA, McCracken JT, London ED (2012) Effects of methamphetamine abuse and serotonin transporter gene variants on aggression and emotion-processing neurocircuitry. Transl Psychiatry 2(2):e80. https://doi.org/10.1038/tp.2011.73CrossRefPubMedPubMedCentral

45.

Bortolato M, Chen K, Shih JC (2008) Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev 60(13–14):1527–1533. https://doi.org/10.1016/J.ADDR.2008.06.002CrossRefPubMedPubMedCentral

46.

Zhang-James Y, Fernàndez-Castillo N, Hess JL et al (2019) An integrated analysis of genes and functional pathways for aggression in human and rodent models. Mol Psychiatry 24(11):1655–1667. https://doi.org/10.1038/S41380-018-0068-7CrossRefPubMed

47.

Kolla NJ, Bortolato M (2020) The role of monoamine oxidase A in the neurobiology of aggressive, antisocial, and violent behavior: A tale of mice and men. Prog Neurobiol 194:101875. https://doi.org/10.1016/J.PNEUROBIO.2020.101875CrossRefPubMedPubMedCentral

48.

Ratey J, Sovner R, Parks A, Rogentine K (1991) Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study. J Clin Psychiatry 52(4):159–162PubMed

49.

Connor DF, Steingard RJ (1996) A clinical approach to the pharmacotherapy of aggression in children and adolescents. Ann N Y Acad Sci 794:290–307. https://doi.org/10.1111/J.1749-6632.1996.TB32529.XCrossRefPubMed

50.

Pabis DJ, Stanislav SW (1996) Pharmacotherapy of aggressive behavior. Ann Pharmacother 30(3):278–287. https://doi.org/10.1177/106002809603000312CrossRefPubMed

51.

de Boer SF, Koolhaas JM (2003) Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur J Pharmacol 463(1–3):145–161. https://doi.org/10.1016/S0014-2999(03)01278-0CrossRefPubMed

52.

Miczek KA, Hussain S, Faccidomo S (1998) Alcohol-heightened aggression in mice: attenuation by 5-HT1A receptor agonists. Psychopharmacology 139(1–2):160–168. https://doi.org/10.1007/S002130050701CrossRefPubMed

53.

de Almeida RMM, Lucion AB (1997) 8-OH-DPAT in the median raphe, dorsal periaqueductal gray and corticomedial amygdala nucleus decreases, but in the medial septal area it can increase maternal aggressive behavior in rats. Psychopharmacology 134(4):392–400. https://doi.org/10.1007/S002130050476CrossRefPubMed

54.

Saudou F, Amara DA, Dierich A et al (1994) Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265(5180):1875–1878. https://doi.org/10.1126/SCIENCE.8091214CrossRefPubMed

55.

Lappalainen J, Long JC, Eggert M et al (1998) Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch Gen Psychiatry 55(11):989–994. https://doi.org/10.1001/ARCHPSYC.55.11.989CrossRefPubMed

56.

Soyka M, Preuss UW, Koller G, Zill P, Bondy B (2004) Association of 5-HT1B receptor gene and antisocial behavior in alcoholism. J Neural Transm (Vienna) 111(1):101–109. https://doi.org/10.1007/S00702-003-0064-0CrossRefPubMed

57.

Zouk H, McGirr A, Lebel V, Benkelfat C, Rouleau G, Turecki G (2007) The effect of genetic variation of the serotonin 1B receptor gene on impulsive aggressive behavior and suicide. Am J Med Genet B Neuropsychiatr Genet 144B(8):996–1002. https://doi.org/10.1002/AJMG.B.30521CrossRefPubMed

58.

Rosell DR, Thompson JL, Slifstein M et al (2010) Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol Psychiatry 67(12):1154–1162. https://doi.org/10.1016/J.BIOPSYCH.2010.03.013CrossRefPubMedPubMedCentral

59.

Coccaro EF, Lee RJ (2019) 5-HT 2c agonist, lorcaserin, reduces aggressive responding in intermittent explosive disorder: A pilot study. Hum Psychopharmacol 34(6):e2714. https://doi.org/10.1002/HUP.2714CrossRefPubMed

60.

Toshchakova VA, Bakhtiari Y, Kulikov A et al (2018) Association of polymorphisms of serotonin transporter (5HTTLPR) and 5-HT2C receptor genes with criminal behavior in russian criminal offenders. Neuropsychobiology 75(4):200. https://doi.org/10.1159/000487484CrossRef

61.

da Cunha-Bang S, McMahon B, MacDonald Fisher P, Steen Jensen P, Svarer C, Knudsen GM (2016) High trait aggression in men is associated with low 5-HT levels, as indexed by 5-HT4 receptor binding. Soc Cogn Affect Neurosci 11(4):548. https://doi.org/10.1093/SCAN/NSV140CrossRefPubMedPubMedCentral

62.

Whipp AM, Korhonen T, Raevuori A et al (2019) Early adolescent aggression predicts antisocial personality disorder in young adults: a population-based study. Eur Child Adolesc Psychiatry 28(3):341–350. https://doi.org/10.1007/S00787-018-1198-9CrossRefPubMed

63.

Giegling I, Hartmann AM, Möller HJ, Rujescu D (2006) Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene. J Affect Disord 96(1–2):75–81. https://doi.org/10.1016/J.JAD.2006.05.016CrossRefPubMed

64.

Banlaki Z, Elek Z, Nanasi T et al (2015) Polymorphism in the serotonin receptor 2a (HTR2A) gene as possible predisposal factor for aggressive traits. PLoS ONE 10(2):e0117792. https://doi.org/10.1371/JOURNAL.PONE.0117792CrossRefPubMedPubMedCentral

65.

Butovskaya ML, Butovskaya PR, Vasilyev VA et al (2018) Serotonergic gene polymorphisms (5-HTTLPR, 5HTR1A, 5HTR2A), and population differences in aggression: traditional (Hadza and Datoga) and industrial (Russians) populations compared. J Physiol Anthropol 37(1):10. https://doi.org/10.1186/S40101-018-0171-0CrossRefPubMedPubMedCentral

66.

Nedic Erjavec G, Tudor L, Nikolac Perkovic M et al (2022) Serotonin 5-HT2A receptor polymorphisms are associated with irritability and aggression in conduct disorder. Prog Neuropsychopharmacol Biol Psychiatry 117:110542. https://doi.org/10.1016/J.PNPBP.2022.110542CrossRefPubMed

67.

Barbas H, de Olmos J (1990) Projections from the amygdala to basoventral and mediodorsal prefrontal regions in the rhesus monkey. J Comp Neurol 300(4):549–571. https://doi.org/10.1002/CNE.903000409CrossRefPubMed

68.

Morecraft RJ, Geula C, Mesulam MM (1992) Cytoarchitecture and neural afferents of orbitofrontal cortex in the brain of the monkey. J Comp Neurol 323(3):341–358. https://doi.org/10.1002/CNE.903230304CrossRefPubMed

69.

Salzman CD, Fusi S (2010) Emotion, cognition, and mental state representation in amygdala and prefrontal cortex. Annu Rev Neurosci 33:173–202. https://doi.org/10.1146/ANNUREV.NEURO.051508.135256CrossRefPubMedPubMedCentral

70.

Stein JL, Wiedholz LM, Bassett DS et al (2007) A validated network of effective amygdala connectivity. Neuroimage 36(3):736–745. https://doi.org/10.1016/J.NEUROIMAGE.2007.03.022CrossRefPubMed

71.

Frokjaer VG, Mortensen EL, Nielsen FÅ et al (2008) Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol Psychiatry 63(6):569–576. https://doi.org/10.1016/J.BIOPSYCH.2007.07.009CrossRefPubMed

72.

Fisher PM, Meltzer CC, Price JC et al (2009) Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional coupling. Cereb Cortex 19(11):2499–2507. https://doi.org/10.1093/CERCOR/BHP022CrossRefPubMedPubMedCentral

73.

Hornboll B, MacOveanu J, Rowe J et al (2013) Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala. J Psychopharmacol 27(10):903–914. https://doi.org/10.1177/0269881113494106CrossRefPubMedPubMedCentral

74.

Norbury R, Taylor MJ, Selvaraj S, Murphy SE, Harmer CJ, Cowen PJ (2009) Short-term antidepressant treatment modulates amygdala response to happy faces. Psychopharmacology 206(2):197–204. https://doi.org/10.1007/S00213-009-1597-1CrossRefPubMed

75.

Passamonti L, Crockett MJ, Apergis-Schoute AM et al (2012) Effects of acute tryptophan depletion on prefrontal-amygdala connectivity while viewing facial signals of aggression. Biol Psychiatry 71(1):36–43. https://doi.org/10.1016/J.BIOPSYCH.2011.07.033CrossRefPubMedPubMedCentral

76.

Yildirim BO, Derksen JJL (2013) Systematic review, structural analysis, and new theoretical perspectives on the role of serotonin and associated genes in the etiology of psychopathy and sociopathy. Neurosci Biobehav Rev 37(7):1254–1296. https://doi.org/10.1016/J.NEUBIOREV.2013.04.009CrossRefPubMed

77.

Krakowski M (2003) Violence and serotonin: influence of impulse control, affect regulation, and social functioning. J Neuropsychiatry Clin Neurosci 15(3):294–305. https://doi.org/10.1176/JNP.15.3.294CrossRefPubMed

78.

Coccaro EF, Fanning JR, Phan KL, Lee R (2015) Serotonin and impulsive aggression. CNS Spectr 20(3):295–302. https://doi.org/10.1017/S1092852915000310CrossRefPubMed

79.

da Cunha-Bang S, Knudsen GM (2021) The modulatory role of serotonin on human impulsive aggression. Biol Psychiatry 90(7):447–457. https://doi.org/10.1016/J.BIOPSYCH.2021.05.016CrossRefPubMed

80.

Alia-Klein N, Goldstein RZ, Kriplani A et al (2008) Brain monoamine oxidase A activity predicts trait aggression. J Neurosci 28(19):5099–5104. https://doi.org/10.1523/JNEUROSCI.0925-08.2008CrossRefPubMedPubMedCentral

81.

Caspi A, McCray J, Moffitt TE et al (2002) Role of genotype in the cycle of violence in maltreated children. Science 297(5582):851–854. https://doi.org/10.1126/SCIENCE.1072290CrossRefPubMed

82.

Byrd AL, Manuck SB (2014) MAOA, childhood maltreatment, and antisocial behavior: meta-analysis of a gene-environment interaction. Biol Psychiatry 75(1):9–17. https://doi.org/10.1016/J.BIOPSYCH.2013.05.004CrossRefPubMed

83.

Godar SC, Mosher LJ, Scheggi S et al (2019) Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT 2A receptor activation. Neuropharmacology 159:107513. https://doi.org/10.1016/J.NEUROPHARM.2019.01.028CrossRefPubMedPubMedCentral

84.

Walther DJ, Peter JU, Bashammakh S et al (2003) Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299(5603):76. https://doi.org/10.1126/SCIENCE.1078197CrossRefPubMed

85.

Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG (2004) Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305(5681):217. https://doi.org/10.1126/SCIENCE.1097540CrossRefPubMed

86.

Booij L, Turecki G, Leyton M et al (2012) Tryptophan hydroxylase(2) gene polymorphisms predict brain serotonin synthesis in the orbitofrontal cortex in humans. Mol Psychiatry 17(8):809–817. https://doi.org/10.1038/MP.2011.79CrossRefPubMed

87.

Cools R, Blackwell A, Clark L, Menzies L, Cox S, Robbins TW (2005) Tryptophan depletion disrupts the motivational guidance of goal-directed behavior as a function of trait impulsivity. Neuropsychopharmacology 30(7):1362–1373. https://doi.org/10.1038/SJ.NPP.1300704CrossRefPubMed

88.

Dougherty DM, Richard DM, James LM, Mathias CW (2010) Effects of acute tryptophan depletion on three different types of behavioral impulsivity. Int J Tryptophan Res 3(1):99–111. https://doi.org/10.4137/IJTR.S4317CrossRefPubMedPubMedCentral

89.

Miyazaki K, Miyazaki KW, Sivori G, Yamanaka A, Tanaka KF, Doya K (2020) Serotonergic projections to the orbitofrontal and medial prefrontal cortices differentially modulate waiting for future rewards. Sci Adv. https://doi.org/10.1126/SCIADV.ABC7246CrossRefPubMedPubMedCentral

90.

Wright AM, Zapata A, Baumann MH, Elmore JS, Hoffman AF, Lupica CR (2017) Enduring loss of serotonergic control of orbitofrontal cortex function following contingent and noncontingent cocaine exposure. Cereb Cortex 27(12):5463–5476. https://doi.org/10.1093/CERCOR/BHW312CrossRefPubMed

91.

Li A, Jing D, Dellarco D et al (2021) Role of BDNF in the development of an OFC-amygdala circuit regulating sociability in mouse and human. Mol Psychiatry 26(3):955–973. https://doi.org/10.1038/S41380-019-0422-4CrossRefPubMed

92.

Vicentic A, Battaglia G, Ivy Carroll F, Kuhar MJ (1999) Serotonin transporter production and degradation rates: studies with RTI-76. Brain Res 841(1–2):1–10. https://doi.org/10.1016/S0006-8993(99)01761-8CrossRefPubMed

93.

Ramamoorthy S, Shippenberg TS, Jayanthi LD (2011) Regulation of monoamine transporters: Role of transporter phosphorylation. Pharmacol Ther 129(2):220–238. https://doi.org/10.1016/J.PHARMTHERA.2010.09.009CrossRefPubMed

94.

Rahbek-Clemmensen T, Bay T, Eriksen J, Gether U, Jrøgensen TN (2014) The serotonin transporter undergoes constitutive internalization and is primarily sorted to late endosomes and lysosomal degradation. J Biol Chem 289(33):23004–23019. https://doi.org/10.1074/JBC.M113.495754CrossRefPubMedPubMedCentral

95.

Li J, Gould TD, Yuan P, Manji HK, Chen G (2003) Postmortem interval effects on the phosphorylation of signaling proteins. Neuropsychopharmacology 28(6):1017–1025. https://doi.org/10.1038/SJ.NPP.1300112CrossRefPubMed

96.

Rajkowska G, Mahajan G, Legutko B et al (2017) Length of axons expressing the serotonin transporter in orbitofrontal cortex is lower with age in depression. Neuroscience 359:30–39. https://doi.org/10.1016/J.NEUROSCIENCE.2017.07.006CrossRefPubMed

Titel: Elevated levels of serotonin 5-HT2A receptors in the orbitofrontal cortex of antisocial individuals
verfasst von: Giulia Braccagni
Simona Scheggi
Marco Bortolato
Publikationsdatum: 12.09.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 2/2023
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-022-01480-y

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Elevated levels of serotonin 5-HT_2A receptors in the orbitofrontal cortex of antisocial individuals

Abstract

Neu im Fachgebiet Psychiatrie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

So wirken verschiedene Alkoholika auf den Blutdruck

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Update Psychiatrie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2023

Insight into the long-term psychological impacts of the COVID-19 pandemic

Possible role of diabetes and related mechanisms in COVID-19-induced cognitive impairment

Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia

Psychological trauma as a transdiagnostic risk factor for mental disorder: an umbrella meta-analysis

One-year results from the vaccination campaign against COVID-19 infection in 47 million individuals with severe mental disorders and other chronic diseases

Childhood maltreatment is associated with cortical thinning in people with eating disorders

Neu im Fachgebiet Psychiatrie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

So wirken verschiedene Alkoholika auf den Blutdruck

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Update Psychiatrie